Ramachandra Sumant
SEC insider (Form 3/4/5 filer). CIK 0001439368. Director at Lyell Immunopharma, Inc. (LYEL). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Ramachandra Sumant has filed insider reports for
- Lyell Immunopharma, Inc. (LYEL): Director
Ramachandra Sumant
CIK: 0001439368
Transaction Breakdown
Open Market Buys (P)1 (25.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LYEL
Lyell Immunopharma, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 10, 2026LYEL
Lyell Immunopharma, Inc.
AwardDirectOption (right to buy)
9.3K shares- - May 15, 2025LYEL
Lyell Immunopharma, Inc.
AwardDirectOption (right to buy)
130K shares- - Mar 21, 2025LYEL
Lyell Immunopharma, Inc.
PurchaseIndirect200K shares at avg. $0.58$115K - Oct 31, 2024LYEL
Lyell Immunopharma, Inc.
AwardDirectOption (right to buy)
260K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 | LYEL Lyell Immunopharma, Inc. | Award Option (right to buy) | 9,250 | - | - | Direct |
| May 15, 2025 | LYEL Lyell Immunopharma, Inc. | Award Option (right to buy) | 130,000 | - | - | Direct |
| Mar 21, 2025 | LYEL Lyell Immunopharma, Inc. | Purchase | 200,000 | $0.58 | $115,220 | Indirect |
| Oct 31, 2024 | LYEL Lyell Immunopharma, Inc. | Award Option (right to buy) | 260,000 | - | - | Direct |
1-4 of 4 transactions